Navigation Links
Advanced Biologics Launches OsteoAMP® Structural at the 26th Annual Meeting of the North American Spine Society
Date:11/1/2011

LADERA RANCH, Calif., Nov. 1, 2011 /PRNewswire/ -- Advanced Biologics, (www.advancedbiologics.com) announced today that they will be launching the newest product within the OsteoAMP® platform during the North American Spine Society (NASS) annual meeting this week in Chicago, IL.  OsteoAMP Structural is the first load-bearing, mineralized, osteoconductive allograft spacer that demonstrates osteoinductive properties in-vivo.  Initial product offerings will include both parallel and lordotic options for use in cervical spine procedures.

Unlike previous surface-demineralized allograft cortical spacers that claim to possess superficial osteoinductivity, the OsteoAMP cortical-cancellous cervical allografts are processed differently where native growth factors are preserved much more efficiently.  OsteoAMP Structural provides a surgeon the ability to use a single product to fulfill osteoinductive, osteoconductive, and structural requirements for spine fusion.  In addition, OsteoAMP Structural enables hospitals the opportunity to reduce case costs without compromising clinical results. 

"We are excited to be part of a safer solution considering the complications recently reported with rhBMP-2 (Infuse).  This format is a great addition to the existing OsteoAMP platform of products," stated Amit Govil, president and founder of Advanced Biologics.

The OsteoAMP process has the ability to harvest the various growth factors found within the bone marrow of an allograft donor and bind them to the surrounding bone tissue.  The result is a greater osteoinductive potential than seen before within the allograft industry, with over 100 times the level of growth factors compared to market-leading DBMs.  Other OsteoAMP formats currently available, include; granules, putty and a compressible sponge.

About Advanced Biologics

Founded in 2009, Advanced Biologics (ABC) is a privately-held company focused on developing innovative and clinically relevant biologic solutions across a wide degree of medical specialties.  The OsteoAMP® family of osteoinductive/conductive products is the first line of orthobiologic offerings produced by ABC.  ABC was awarded the Best New Regenerative Technology award in 2009 and the Best New Biomaterial Technology Award in 2010 by the Orthopedics This Week Spine Technology Awards.  Other technology platforms to follow include an allograft derived stem cell product and a shape-memory, anti-bacterial synthetic portfolio. 


'/>"/>
SOURCE Advanced Biologics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Australias Prince of Wales Hospital Launches New Era of Targeted Lung Cancer Treatments with Elektas Advanced 4D Motion Management Technology
2. Misonix Exhibits BoneScalpel™ at the International Meeting on Advanced Spine Techniques
3. Invuity Introduces Advanced Illuminated Surgical System for Breast Procedures
4. Major Diagnostic Breakthrough in Multiple Sclerosis Achieved with Advanced FONAR UPRIGHT® MRI
5. Halozyme Begins Randomized, Controlled Clinical Trial with PEGPH20 in Patients with Advanced Pancreatic Cancer
6. CIVCO Appoints Andres Ramirez Sales Director of Advanced Robotics and Workflow Solutions
7. Innocoll Provides an Update on its Range of Advanced Wound Care and Related Collagen-based Products
8. meridianEMR Advanced Monitoring System Catches Security Breach
9. Advanced Health Media, Inc. Announces New SVP Product Delivery
10. Advanced Health Media, Inc. Announces New CFO
11. Unrestricted Access to Advanced Imaging a Top Priority for Consumers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... , Jan. 20, 2017 ARMO BioSciences, Inc., ... data on the Company,s lead investigational immuno-oncology drug AM0010 ... by the American Society of Clinical Oncology (ASCO), taking ... CA. "AM0010 induces the ... + T cells in the blood and tumors ...
(Date:1/21/2017)... -- Research and Markets has announced the addition of ... Route Of Administration, End User - Forecast to 2025" report ... ... a CAGR of around 7.8% over the next decade to reach ... analyzes the global markets for Advanced Drug Delivery across all the ...
(Date:1/20/2017)... , Jan 20, 2017 Research and ... Market By Type ([CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, HbA1c ... End-use, And Segment Forecasts, 2013 - 2024" report to their ... The ... billion by 2024 Introduction of innovative solutions on the ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... January 20, 2017 , ... A new partnership between Goodwill® ... no longer use or need, from clothes to couches to dressers and bicycles. Roadie ... take them to the nearest Goodwill donation center through February 28th. , “January ...
(Date:1/20/2017)... ... 20, 2017 , ... Doctor C LLC, a company based out of Arizona ... to continue the marketing and distribution of its product, The Right C. , The ... better absorption than traditional vitamin C supplements. At the trade show, Doctor C had ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, ... everyday lives, recently attended the January ECRM Trade Show in Hilton Head, SC, ... for its large range of supplements that keep the body functioning at its ...
(Date:1/20/2017)... Viejo, California (PRWEB) , ... January 20, 2017 , ... ... easy to use inside of Final Cut Pro X," said Christina Austin - CEO ... on the RED Dragon. Utilizing the Dragon Sensor,TransFlare 4K Mystique lens flare and light ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and earnest tale ... each of his children. “The Angel” is the creation of published author, Marjorie Lund-Fontaine, ... City, and impassioned writer. , When asked of her new book, Marjorie says, “‘The ...
Breaking Medicine News(10 mins):